Rapamycin is a Food and Drug Administration (FDA)-approved immunosuppressant and anticancer agent discovered in the soil of Easter Island in the early 1970s
Dysregulation of mTOR
Rapamycin is a Food and Drug Administration (FDA)-approved immunosuppressant and anticancer agent discovered in the soil of Easter Island in the early 1970s
Rapamycin plus acarbose, starting at 9 months of age (RaAc9)
Acarbose; 17% Lifespan Improvement Alone, and Up to 29% When Combined with Rapamycin
Here we compare the effects of Acarbose; 17% Lifespan Improvement Alone, and Up to 29% When Combined with Rapamycin
Acarbose; 17% Lifespan Improvement Alone, and Up to 29% When Combined with Rapamycin
There have been three major acarbose lifespan studies that all showed significant life extension results, with up to 17% lifespan increase seen in
Acarbose; 17% Lifespan Improvement Alone, and Up to 29% When Combined with Rapamycin
Acarbose; 17% Lifespan Improvement Alone, and Up to 29% When Combined with Rapamycin
I’ve lost about 10 pounds
Adding rapamycin or acarbose to diet at 9-10 months of age has been shown to significantly increase life span in both male and female UM-HET3 mice
A cocktail of rapamycin, acarbose and phenylbutyrate prevents age-related cognitive decline in mice by altering aging pathways September 2022 DOI: 10
This combination of agents produced a 28% increase in median lifespan in females (p < 0
Acarbose is another leading anti-aging drug that is FDA approved, and available today
When mice were given a combination of acarbose and rapamycin, it resulted in a 34% median lifespan increase in males and a 28% increase
Longevity drug candidates are the antidiabetic drugs metformin and acarbose, and the immunosuppressant rapamycin
Another study tested the combination of Rapamycin and Acarbose and found it to be the most robust longevity-enhancing intervention to date